EUVIMEDEUVIMED entdecken
Open Access

Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome

Alexandra Lebensohn, Azam Ghafoor, Luke Bloomquist, Michael C Royer, Leslie Castelo-Soccio, Kelli Karacki, Olanda Hathaway, Tenin Maglo, Cathy Wagner, Maria G Agra, Andrew M Blakely, David S Schrump und 2 weitere

JAMA Dermatology · 2024

DOI: 10.1001/jamadermatol.2024.1804 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA Dermatology, 2024. Verfasst von Alexandra Lebensohn und 13 weiteren Autor:innen. Beteiligte Einrichtung: Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Hauptthemen laut MEDLINE: Ubiquitin Thiolesterase, Tumor Suppressor Proteins, Skin Neoplasms, Germ-Line Mutation. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance BRCA1 -associated protein (BAP1) tumor predisposition syndrome (TPDS) is a cancer genodermatosis associated with high risk of uveal and cutaneous melanoma, basal cell carcinoma, and multiple internal malignant neoplasms, including mesothelioma and renal cell carcinoma. Early detection of the syndrome is important for cancer surveillance and genetic counseling of family members who are at risk.

Objective

To determine the prevalence of nail abnormalities in individuals with pathogenic germline variants in BAP1 . Design, Setting, and Participants In this prospective cohort study, individuals who were known carriers of pathogenic BAP1 germline variants were consecutively enrolled between October 10, 2023, and March 15, 2024. Dermatologic evaluation for nail abnormalities was performed, including a history of nail abnormalities and associated symptoms, physical examination, medical photography, and nail biopsy for histopathology. This was a single-center study conducted at the National Institutes of Health Clinical Center. Main Outcomes and Measures Primary outcomes were the prevalence and spectrum of nail changes and histopathologic characterization.

Results

Among 47 participants (30 female [63.8%]; mean [SD] age, 46.4 [15.1] years) ranging in age from 13 to 72 years from 35 families, nail abnormalities were detected in 41 patients (87.2%) and included leukonychia, splinter hemorrhage, onychoschizia, and distal nail hyperkeratosis. Clinical findings consistent with onychopapilloma were detected in 39 patients (83.0%), including 35 of 40 individuals aged 30 years or older (87.5%). Nail bed biopsy was performed in 5 patients and was consistent with onychopapilloma. Polydactylous involvement with onychopapillomas was detected in nearly all patients who had nail involvement (38 of 39 patients [97.4%]). Conclusions and Relevance This study found that BAP1 TPDS was associated with a high rate of nail abnormalities consistent with onychopapillomas in adult carriers of the disease. Findings suggest that this novel cutaneous sign may facilitate detection of the syndrome in family members who are at risk and patients with cancers associated with BAP1 given that multiple onychopapillomas are uncommon in the general population and may be a distinct clue to the presence of a pathogenic germline variant in the BAP1 gene.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ubiquitin ThiolesteraseTumor Suppressor ProteinsSkin NeoplasmsGerm-Line MutationGenetic Predisposition to DiseaseHumansFemaleMaleMiddle AgedAdultProspective StudiesAgedYoung AdultAdolescentNail DiseasesPrevalencePapillomaNeoplastic Syndromes, HereditaryNails, Malformed

Substanzen

Ubiquitin ThiolesteraseBAP1 protein, humanTumor Suppressor Proteins

Autor:innen und Institutionen

  • Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Thoracic and Gastrointestinal Malignancies Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
  • Department of Dermatology, Walter Reed National Military Medical Center.
  • Division of Dermatopathology, Joint Pathology Center, Silver Spring, Maryland.
  • Dermatology Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland.
  • Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

Zitieren

APA

Lebensohn, A., Ghafoor, A., Bloomquist, L., Royer, M. C., Castelo-Soccio, L., Karacki, K., Hathaway, O., Maglo, T., Wagner, C., Agra, M. G., Blakely, A. M., Schrump, D. S., Hassan, R., & Cowen, E. W. (2024). Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome. JAMA Dermatology. https://doi.org/10.1001/jamadermatol.2024.1804

Vancouver

Lebensohn A, Ghafoor A, Bloomquist L, Royer MC, Castelo-Soccio L, Karacki K, et al. Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome. JAMA Dermatology. 2024. doi:10.1001/jamadermatol.2024.1804

BibTeX
@article{Lebensohn2024,
  author = {Lebensohn, Alexandra and Ghafoor, Azam and Bloomquist, Luke and Royer, Michael C and Castelo-Soccio, Leslie and Karacki, Kelli and Hathaway, Olanda and Maglo, Tenin and Wagner, Cathy and Agra, Maria G and Blakely, Andrew M and Schrump, David S and Hassan, Raffit and Cowen, Edward W},
  title = {Multiple Onychopapillomas and BAP1 Tumor Predisposition Syndrome},
  journal = {JAMA Dermatology},
  year = {2024},
  doi = {10.1001/jamadermatol.2024.1804}
}
Kostenlos starten →